Precision Medicine: Disease Subtyping and Tailored Treatment

Cancers (Basel). 2023 Jul 28;15(15):3837. doi: 10.3390/cancers15153837.

Abstract

The genomics-based concept of precision medicine began to emerge following the completion of the Human Genome Project. In contrast to evidence-based medicine, precision medicine will allow doctors and scientists to tailor the treatment of different subpopulations of patients who differ in their susceptibility to specific diseases or responsiveness to specific therapies. The current precision medicine model was proposed to precisely classify patients into subgroups sharing a common biological basis of diseases for more effective tailored treatment to achieve improved outcomes. Precision medicine has become a term that symbolizes the new age of medicine. In this review, we examine the history, development, and future perspective of precision medicine. We also discuss the concepts, principles, tools, and applications of precision medicine and related fields. In our view, for precision medicine to work, two essential objectives need to be achieved. First, diseases need to be classified into various subtypes. Second, targeted therapies must be available for each specific disease subtype. Therefore, we focused this review on the progress in meeting these two objectives.

Keywords: big data analytics; biomarkers; electronic health record; functional precision medicine; multiomics; pharmaco-omics; precision medicine; subtyping; tailored treatment; targeted therapy.

Publication types

  • Review